Entry - #610374 - DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2 - OMIM

# 610374

DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
11p15.1 Diabetes mellitus, transient neonatal 2 610374 AD 3 ABCC8 600509
Clinical Synopsis
 

INHERITANCE
- Autosomal dominant
GROWTH
Weight
- Low-birth weight (some patients)
NEUROLOGIC
Central Nervous System
- Dystonia (rare)
- Mild visual dyspraxia (rare)
- Mild spatial dyspraxia (rare)
ENDOCRINE FEATURES
- Transient neonatal diabetes mellitus
- Remitting diabetes mellitus
- Polyuria
- Polydipsia
- Ketoacidosis
LABORATORY ABNORMALITIES
- Hyperglycemia
- Negative anti-islet antibodies
MISCELLANEOUS
- Onset as newborn (age range: 3-74 days)
- Responsive to oral sulfonylurea
- Family history of type II diabetes mellitus and gestational diabetes
MOLECULAR BASIS
- Caused by mutation in the ATP-binding cassette, subfamily C, member 8 gene (ABCC8, 600509.0019)

TEXT

A number sign (#) is used with this entry because of evidence that transient neonatal diabetes mellitus-2 (TNDM2) is caused by heterozygous mutation in the ABCC8 gene (600509) on chromosome 11p15.

For a phenotypic description and a discussion of genetic heterogeneity of transient neonatal diabetes mellitus, see 601410.


Molecular Genetics

From a group of 73 patients with neonatal diabetes, Babenko et al. (2006) screened the ABCC8 gene in 34 who did not have alterations in chromosome 6q (see 601410) or mutations in the KCNJ11 (600937) or GCK (138079) genes. They identified heterozygosity for 5 different mutations (see, e.g., 600509.0019 and 600509.0020) in 7 patients with transient neonatal diabetes mellitus. They also identified heterozygosity for mutations (600509.0017 and 600509.0018) in 2 patients with permanent neonatal diabetes (PNDM3; 618857). Mutant channels in intact cells and in physiologic concentrations of magnesium ATP had markedly higher activity than did wildtype channels. These overactive channels remained sensitive to sulfonylurea, and treatment with sulfonylureas resulted in euglycemia. The mutation-positive fathers of 5 of the probands with TNDM developed type II diabetes mellitus (125853) in adulthood; Babenko et al. (2006) proposed that mutations of the ABCC8 gene may give rise to a monogenic form of type II diabetes with variable expression and age at onset. The authors noted that dominant mutations in ABCC8 accounted for 12% of cases of neonatal diabetes in the study group.


REFERENCES

  1. Babenko, A. P., Polak, M., Cave, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., Froguel, P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. New Eng. J. Med. 355: 456-466, 2006. [PubMed: 16885549, related citations] [Full Text]


Contributors:
Victor A. McKusick - updated : 2/21/2007
Creation Date:
Marla J. F. O'Neill : 9/5/2006
alopez : 12/01/2020
carol : 05/04/2020
alopez : 04/30/2020
alopez : 02/23/2007
terry : 2/21/2007
carol : 9/5/2006
carol : 9/5/2006

# 610374

DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2


SNOMEDCT: 609580007;   ORPHA: 99886;   DO: 0060334;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
11p15.1 Diabetes mellitus, transient neonatal 2 610374 Autosomal dominant 3 ABCC8 600509

TEXT

A number sign (#) is used with this entry because of evidence that transient neonatal diabetes mellitus-2 (TNDM2) is caused by heterozygous mutation in the ABCC8 gene (600509) on chromosome 11p15.

For a phenotypic description and a discussion of genetic heterogeneity of transient neonatal diabetes mellitus, see 601410.


Molecular Genetics

From a group of 73 patients with neonatal diabetes, Babenko et al. (2006) screened the ABCC8 gene in 34 who did not have alterations in chromosome 6q (see 601410) or mutations in the KCNJ11 (600937) or GCK (138079) genes. They identified heterozygosity for 5 different mutations (see, e.g., 600509.0019 and 600509.0020) in 7 patients with transient neonatal diabetes mellitus. They also identified heterozygosity for mutations (600509.0017 and 600509.0018) in 2 patients with permanent neonatal diabetes (PNDM3; 618857). Mutant channels in intact cells and in physiologic concentrations of magnesium ATP had markedly higher activity than did wildtype channels. These overactive channels remained sensitive to sulfonylurea, and treatment with sulfonylureas resulted in euglycemia. The mutation-positive fathers of 5 of the probands with TNDM developed type II diabetes mellitus (125853) in adulthood; Babenko et al. (2006) proposed that mutations of the ABCC8 gene may give rise to a monogenic form of type II diabetes with variable expression and age at onset. The authors noted that dominant mutations in ABCC8 accounted for 12% of cases of neonatal diabetes in the study group.


REFERENCES

  1. Babenko, A. P., Polak, M., Cave, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., Froguel, P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. New Eng. J. Med. 355: 456-466, 2006. [PubMed: 16885549] [Full Text: https://doi.org/10.1056/NEJMoa055068]


Contributors:
Victor A. McKusick - updated : 2/21/2007

Creation Date:
Marla J. F. O'Neill : 9/5/2006

Edit History:
alopez : 12/01/2020
carol : 05/04/2020
alopez : 04/30/2020
alopez : 02/23/2007
terry : 2/21/2007
carol : 9/5/2006
carol : 9/5/2006